AZD4604, AZD4604 Placebo, AZD4604
D8210C00003
Phase 2 small_molecule active
Quick answer
AZD4604, AZD4604 Placebo, AZD4604 for Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active